全文获取类型
收费全文 | 26684篇 |
免费 | 1944篇 |
国内免费 | 77篇 |
专业分类
耳鼻咽喉 | 399篇 |
儿科学 | 745篇 |
妇产科学 | 561篇 |
基础医学 | 3767篇 |
口腔科学 | 282篇 |
临床医学 | 2647篇 |
内科学 | 5491篇 |
皮肤病学 | 537篇 |
神经病学 | 2632篇 |
特种医学 | 1212篇 |
外科学 | 4374篇 |
综合类 | 259篇 |
一般理论 | 23篇 |
预防医学 | 1819篇 |
眼科学 | 452篇 |
药学 | 1771篇 |
中国医学 | 28篇 |
肿瘤学 | 1706篇 |
出版年
2023年 | 297篇 |
2022年 | 557篇 |
2021年 | 1134篇 |
2020年 | 640篇 |
2019年 | 964篇 |
2018年 | 1087篇 |
2017年 | 742篇 |
2016年 | 764篇 |
2015年 | 950篇 |
2014年 | 1196篇 |
2013年 | 1505篇 |
2012年 | 2185篇 |
2011年 | 2221篇 |
2010年 | 1190篇 |
2009年 | 942篇 |
2008年 | 1462篇 |
2007年 | 1478篇 |
2006年 | 1395篇 |
2005年 | 1211篇 |
2004年 | 1086篇 |
2003年 | 928篇 |
2002年 | 826篇 |
2001年 | 287篇 |
2000年 | 211篇 |
1999年 | 229篇 |
1998年 | 159篇 |
1997年 | 118篇 |
1996年 | 119篇 |
1995年 | 87篇 |
1994年 | 69篇 |
1993年 | 67篇 |
1992年 | 132篇 |
1991年 | 123篇 |
1990年 | 110篇 |
1989年 | 128篇 |
1988年 | 90篇 |
1987年 | 104篇 |
1986年 | 102篇 |
1985年 | 88篇 |
1984年 | 78篇 |
1983年 | 64篇 |
1982年 | 64篇 |
1981年 | 66篇 |
1980年 | 51篇 |
1979年 | 65篇 |
1978年 | 54篇 |
1974年 | 52篇 |
1973年 | 64篇 |
1972年 | 62篇 |
1940年 | 48篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
Beighley Adam Glynn Ryan Scullen Tyler Mathkour Mansour Werner Cassidy Berry John F. Carr Christopher Abou-Al-Shaar Hussam Aysenne Aimee Nerva John D. Dumont Aaron S. 《Neurosurgical review》2021,44(5):2511-2522
Neurosurgical Review - Aneurysmal subarachnoid hemorrhage (aSAH) is an emergent condition requiring rapid intervention and prolonged monitoring. There are few recommendations regarding the... 相似文献
72.
Adam Kwapisz 《Arthroscopy》2021,37(1):59-60
The first national medical database registry was started in Sweden in 1975, and clinical registries have gained enormous popularity. Analysis of a large database of rotator cuff repair surgeries shows that adverse events may occur in almost 1 of 5 cases, showing the use of a register as a highly beneficial source of information. However, retrospective review of prospectively collected registry data has limitations and biases as well as benefits, including inconsistent reporting and recording of data, lack of control of confounding patient variables, and loss to follow-up. 相似文献
73.
Isabel M. A. Brüggenwirth Maureen J. M. Werner René Adam Wojciech G. Polak Vincent Karam Michael A. Heneghan Arianeb Mehrabi Jürgen L. Klempnauer Andreas Paul Darius F. Mirza Johann Pratschke Mauro Salizzoni Daniel Cherqui Michael Allison Olivier Soubrane Steven J. Staffa David Zurakowski Robert J. Porte Vincent E. de Meijer all the other contributing centers the European Liver Intestine Transplant Association 《Transplant international》2021,34(10):1928-1937
High-risk combinations of recipient and graft characteristics are poorly defined for liver retransplantation (reLT) in the current era. We aimed to develop a risk model for survival after reLT using data from the European Liver Transplantation Registry, followed by internal and external validation. From 2006 to 2016, 85 067 liver transplants were recorded, including 5581 reLTs (6.6%). The final model included seven predictors of graft survival: recipient age, model for end-stage liver disease score, indication for reLT, recipient hospitalization, time between primary liver transplantation and reLT, donor age, and cold ischemia time. By assigning points to each variable in proportion to their hazard ratio, a simplified risk score was created ranging 0–10. Low-risk (0–3), medium-risk (4–5), and high-risk (6–10) groups were identified with significantly different 5-year survival rates ranging 56.9% (95% CI 52.8–60.7%), 46.3% (95% CI 41.1–51.4%), and 32.1% (95% CI 23.5–41.0%), respectively (P < 0.001). External validation showed that the expected survival rates were closely aligned with the observed mortality probabilities. The Retransplantation Risk Score identifies high-risk combinations of recipient- and graft-related factors prognostic for long-term graft survival after reLT. This tool may serve as a guidance for clinical decision-making on liver acceptance for reLT. 相似文献
74.
Fabio Casciani Maxwell T. Trudeau Horacio J. Asbun Chad G. Ball Claudio Bassi Stephen W. Behrman Adam C. Berger Mark P. Bloomston Mark P. Callery John D. Christein Massimo Falconi Carlos Fernandez-del Castillo Mary E. Dillhoff Euan J. Dickson Elijah Dixon William E. Fisher Michael G. House Steven J. Hughes John W. Kunstman 《Surgery》2021,169(4):708-720
BackgroundPancreatoduodenectomies at high risk for clinically relevant pancreatic fistula are uncommon, yet intimidating, situations. In such scenarios, the impact of individual surgeon experience on outcomes is poorly understood.MethodsThe fistula risk score was applied to identify high-risk patients (fistula risk score 7–10) from 7,706 pancreatoduodenectomies performed at 18 international institutions (2003–2020). For each case, surgeon pancreatoduodenectomy career volume and years of practice were linked to intraoperative fistula mitigation strategy adoption and outcomes. Consequently, best operative approaches for clinically relevant pancreatic fistula prevention and best performer profiles were identified through multivariable analysis models.ResultsEight hundred and thirty high-risk pancreatoduodenectomies, performed by 64 surgeons, displayed an overall clinically relevant pancreatic fistula rate of 33.7%. Clinically relevant pancreatic fistula rates decreased with escalating surgeon career pancreatoduodenectomy (–49.7%) and career length (–41.2%; both P < .001), as did transfusion and reoperation rates, postoperative morbidity index, and duration of stay. Great experience (≥400 pancreatoduodenectomies performed or ≥21-year-long career) was a significant predictor of clinically relevant pancreatic fistula prevention (odds ratio 0.52, 95% confidence interval 0.35–0.76) and was more often associated with pancreatojejunostomy reconstruction and prophylactic octreotide omission, which were both independently associated with clinically relevant pancreatic fistula reduction. A risk-adjusted performance analysis also correlated with experience. Moreover, minimizing blood loss (≤400 mL) significantly contributed to clinically relevant pancreatic fistula prevention (odds ratio 0.40, 95% confidence interval 0.22–0.74).ConclusionSurgeon experience is a key contributor to achieve better outcomes after high-risk pancreatoduodenectomy. Surgeons can improve their performance in these challenging situations by employing pancreatojejunostomy reconstruction, omitting prophylactic octreotide, and minimizing blood loss. 相似文献
75.
76.
Giuliante Felice Viganò Luca De Rose Agostino M. Mirza Darius F. Lapointe Réal Kaiser Gernot Barroso Eduardo Ferrero Alessandro Isoniemi Helena Lopez-Ben Santiago Popescu Irinel Ouellet Jean-Francois Hubert Catherine Regimbeau Jean-Marc Lin Jen-Kou Skipenko Oleg G. Ardito Francesco Adam René 《Annals of surgical oncology》2021,28(13):8198-8208
Annals of Surgical Oncology - The liver-first approach in patients with synchronous colorectal liver metastases (CRLM) has gained wide consensus but its role is still to be clarified. We aimed to... 相似文献
77.
78.
79.
Nathan Perlis Antonio Finelli Mike Lovas Alejandro Berlin Janet Papadakos Sangeet Ghai Vasiliki Bakas Shabbir Alibhai Odelia Lee Adam Badzynski David Wiljer Alexis Lund Amelia Di Meo Joseph Cafazzo Masoom Haider 《Canadian Urological Association journal》2021,15(4):108
IntroductionAs we progress to an era when patient autonomy and shared decision-making are highly valued, there is a need to also have effective patient-centered communication tools. Radiology reports are designed for clinicians and can be very technical and difficult for patients to understand. It is important for patients to understand their magnetic resonance imaging (MRI) report in order to make an informed treatment decision with their physician. Therefore, we aimed to create a patient-centered prostate MRI report to give our patients a better understanding of their clinical condition.MethodsA prototype patient-centered radiology report (PACERR) was created by identifying items to include based on opinions sought from a group of patients undergoing prostate MRI and medical experts. Data was collected in semi-structured interviews using a salient belief question. A prototype PACERR was created in collaboration with human factors engineering and design, medical imaging, biomedical informatics, and cancer patient education groups.ResultsFifteen patients and eight experts from urology, radiation oncology, radiology, and nursing participated in this study. Patients were particularly interested to have a report with laymen terms, concise language, contextualization of values, definitions of medical terms, and next course of action. Everyone believed the report should include the risk of MRI findings actually being cancer in the subsequent biopsy.ConclusionsA prostate MRI PACERR has been developed to communicate the most important findings relevant to decision-making in prostate cancer using patient-oriented design principles. The ability of this tool to improve patient knowledge and communication will be explored. 相似文献
80.
Melody R. Palmer Daniel S. Kim David R. Crosslin Ian B. Stanaway Elisabeth A. Rosenthal David S. Carrell David J. Cronkite Adam Gordon Xiaomeng Du Yatong K. Li Marc S. Williams Chunhua Weng Qiping Feng Rongling Li Sarah A. Pendergrass Hakon Hakonarson David Fasel Sunghwan Sohn Patrick Sleiman Samuel K. Handelman Elizabeth Speliotes Iftikhar J. Kullo Eric B. Larson Gail P. Jarvik 《Genetic epidemiology》2021,45(1):4-15